Mechanisms and Potential Therapeutic Use of Dihydromyricetin in Reducing Alcoholic Liver Disorder and Alcohol Abuse Disorder Behavior
Mentor: Dr. Daryl L. Davies
- Research Significance and Research Goal:
Dihydromyricetin (DHM), a bioactive flavanonol isolated from the Ampelopsis grossedentata species, is becoming recognized for its broad range of pharmacological properties, including antioxidative, anti-inflammatory, anticancer, antimicrobial, cell death-mediating and metabolism-mediating activities. Acting as an antioxidant, DHM can potentially counteract ethanol intoxication, reduce consumption, and protect cells against oxidative stress. To promote the efficacy and safety of DHM as a new therapeutic for the reduction/prevention of alcoholic liver disorder(ALD) and alcohol abuse disorder (AUD), we must first utilize in vitro studies to preliminarily elucidate its mechanisms and potential. By investigating DHM in these models, we will provide insight into the pharmacological benefits of DHM for a disorder with little to no effective treatment options.
- Experimental Design
- Cell Culture
Hep G2 cells and VL17A cells are cultured at 37℃ in a humidified atmosphere with 5% CO2
- MTT Cell Viability and Proliferation Assay
Test the viability and proliferation of Hep G2 cells and VL17A cells with or without DHM treatment in the presence of alcohol.
- Fluorescent Staining and Imaging
Observe the amount of acidic vacuoles(autophagolysomes, lysosomes, and other lysome-related vacuoles) with or without DHM treatment in the presence of alcohol.
- Western Blot Analysis
Analyze the expression of LCI, LC-II, Ulk1, p-Ulk1, mTOR, p-mTOR, PI3K85, PI3K110, Akt, p-Akt, Erk, p-Erk, AMPK, p-AMPK in Hep G2 cells and VL17A cells with or without DHM treatment in the presence of alcohol.
- Blocking of Autophagy Pathway
Observe the effect of DHM in autophagy-blocked HepG2 and VL 17A cells.
- Timeline
February: Read literature and design experiments
课题毕业论文、文献综述、任务书、外文翻译、程序设计、图纸设计等资料可联系客服协助查找。